| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP &Chief Medical Officer
1 company
Gergel Ivan P. is a SVP &Chief Medical Officer at NEKTAR THERAPEUTICS. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $3.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2017 | NKTR Nektar Therapeutics | SVP &Chief Medical Officer | Sale+OE | 100,000 | $24.14 | $2,413,639.68 | -54.6% | |
| Aug 16, 2017 | NKTR Nektar Therapeutics | SVP &Chief Medical Officer | Sell | 1,997 | $19.32 | $38,582.04 | -4.6% | |
| Jul 18, 2017 | NKTR Nektar Therapeutics | SVP &Chief Medical Officer | Sale+OE | 54,920 | $21.10 | $1,158,812.00 | -55.8% | |
| Jul 12, 2017 | NKTR Nektar Therapeutics | SVP &Chief Medical Officer | Sale+OE | 45,080 | $21.08 | $950,317.75 | -34.1% | |
| May 16, 2017 | NKTR Nektar Therapeutics | SVP &Chief Medical Officer | Sell | 1,450 | $19.55 | $28,347.50 | -3.2% | |
| Feb 16, 2017 | NKTR Nektar Therapeutics | SVP &Chief Medical Officer | Sell | 1,457 | $13.14 | $19,144.98 | -3.1% | |
| Nov 16, 2016 | NKTR Nektar Therapeutics | SVP &Chief Medical Officer | Sell | 848 | $13.96 | $11,838.08 | -3.1% | |
| Aug 16, 2016 | NKTR Nektar Therapeutics | SVP &Chief Medical Officer | Sell | 1,685 | $17.56 | $29,588.60 | -5.8% | |
| May 17, 2016 | NKTR Nektar Therapeutics | SVP &Chief Medical Officer | Sale+OE | 432 | $13.58 | $5,866.56 | -22.2% | |
| Feb 17, 2016 | NKTR Nektar Therapeutics | SVP &Chief Medical Officer | Sale+OE | 556 | $11.92 | $6,627.52 | -44.5% |